By exploitingthe intrinsic binding properties of AFt to TfR-1 and the breast cancercells’ enhanced TfR-1 expression, AFt-encapsulation of JAaconfers a significant degree of cancer-selectivity. The gene discussed is TFRC; the disease is medical procedure.